Author Question: Dr. Who is planning to apply for federal funding from the NIH for his study comparing two distinct ... (Read 68 times)

pragya sharda

  • Hero Member
  • *****
  • Posts: 566
Dr. Who is planning to apply for federal funding from the NIH for his study comparing two distinct forms of therapy he encountered during his travels. He will be most likely to get funded if he uses
 
  a. between-subjects design.
  b. within-subjects design.
  c. randomized clinical trials.
  d. Therapy and Research Design International Standards (TARDIS).

Question 2

The psychoanalytic and behavioral traditions often look at an individual subject's response to treatment over time. In evaluating response to treatment, these clinicians are likely to use the
 
  a. between-subjects design.
  b. within-subjects design.
  c. baseline measurements design.
  d. none of the above, it is impossible to gain useful information from a single subject.



nothere

  • Sr. Member
  • ****
  • Posts: 324
Answer to Question 1

c

Answer to Question 2

wohoo thank youuu.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

In Eastern Europe and Russia, interferon is administered intranasally in varied doses for the common cold and influenza. It is claimed that this treatment can lower the risk of infection by as much as 60–70%.

Did you know?

The top 10 most important tips that will help you grow old gracefully include (1) quit smoking, (2) keep your weight down, (3) take supplements, (4) skip a meal each day or fast 1 day per week, (5) get a pet, (6) get medical help for chronic pain, (7) walk regularly, (8) reduce arguments, (9) put live plants in your living space, and (10) do some weight training.

Did you know?

In 2010, opiate painkllers, such as morphine, OxyContin®, and Vicodin®, were tied to almost 60% of drug overdose deaths.

Did you know?

A seasonal flu vaccine is the best way to reduce the chances you will get seasonal influenza and spread it to others.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

For a complete list of videos, visit our video library